Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per S Sørensen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Neurology|May 3, 2021
Editorial: Challenges in the diagnosis and treatment of multiple sclerosisPer S Sørensen
Current Opinion in Neurology|April 12, 2021
Highly effective disease-modifying treatment as initial MS therapyKlaus Schmierer, Per S Sørensen, David Baker
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2012
Prediction of antibody persistency from antibody titres to natalizumabPoul Erik H Jensen, Nils Koch-Henriksen, Finn Sellebjerg, et al.
Asian Journal of Urology|August 4, 2020
Efficacy and safety of degarelix in patients with prostate cancer: Results from a phase III study in ChinaYinghao Sun, Liping Xie, Tao Xu, et al.
Brain : a Journal of Neurology|September 22, 2010
Demyelination versus remyelination in progressive multiple sclerosisStephan Bramow, Josa M Frischer, Hans Lassmann, et al.
Neurology|January 19, 2018
Smoking affects the interferon beta treatment response in multiple sclerosisEva R Petersen, Annette B Oturai, Nils Koch-Henriksen, et al.
Lancet (London, England)|September 29, 2004
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trialOtto R Hommes, Per S Sørensen, Franz Fazekas, et al.
Brain Pathology (Zurich, Switzerland)|October 26, 2024
Subcortical plaques and inflammation reflect cortical and meningeal pathologies in progressive multiple sclerosisBetül Okutan, Jette L Frederiksen, Gunnar Houen, et al.
Plos One|April 22, 2014
Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivityMark Lyksborg, Hartwig R Siebner, Per S Sørensen, et al.
Journal of Neuroimmunology|June 17, 2008
The SH2D2A gene and susceptibility to multiple sclerosisAslaug R Lorentzen, Cathrine Smestad, Benedicte A Lie, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Neurology|May 3, 2021
Editorial: Challenges in the diagnosis and treatment of multiple sclerosisPer S Sørensen
Current Opinion in Neurology|April 12, 2021
Highly effective disease-modifying treatment as initial MS therapyKlaus Schmierer, Per S Sørensen, David Baker
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2012
Prediction of antibody persistency from antibody titres to natalizumabPoul Erik H Jensen, Nils Koch-Henriksen, Finn Sellebjerg, et al.
Asian Journal of Urology|August 4, 2020
Efficacy and safety of degarelix in patients with prostate cancer: Results from a phase III study in ChinaYinghao Sun, Liping Xie, Tao Xu, et al.
Brain : a Journal of Neurology|September 22, 2010
Demyelination versus remyelination in progressive multiple sclerosisStephan Bramow, Josa M Frischer, Hans Lassmann, et al.
Neurology|January 19, 2018
Smoking affects the interferon beta treatment response in multiple sclerosisEva R Petersen, Annette B Oturai, Nils Koch-Henriksen, et al.
Lancet (London, England)|September 29, 2004
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trialOtto R Hommes, Per S Sørensen, Franz Fazekas, et al.
Brain Pathology (Zurich, Switzerland)|October 26, 2024
Subcortical plaques and inflammation reflect cortical and meningeal pathologies in progressive multiple sclerosisBetül Okutan, Jette L Frederiksen, Gunnar Houen, et al.
Plos One|April 22, 2014
Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivityMark Lyksborg, Hartwig R Siebner, Per S Sørensen, et al.
Journal of Neuroimmunology|June 17, 2008
The SH2D2A gene and susceptibility to multiple sclerosisAslaug R Lorentzen, Cathrine Smestad, Benedicte A Lie, et al.
Pageof 2